Faculty profile

Carlos Cervera

ResearcherMedical Microbiology and ImmunologyUniversity of Alberta

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Alberta directory, so their courses may be missing. Find their university profile.

Carlos Cervera

Researcher

Medical Microbiology and Immunology

Health Sciences

University of Alberta

Edmonton, Alberta, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
17 publications in the last five years, latest in 2026.
Senior (last) author on 6 recent papers, a sign of leading a research group.
Principal investigator on 3 research grants (2 SSHRC, 1 CIHR), most recently in 2022.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Gene Regulation Immunogenetics Inhibitory Receptors Receptor Biology Viral Immune Evasion

Latest papers

Pretransplant screening for infections in lung and heart transplant candidates.
JHLT open · 2026
Cell-mediated Immunity to Guide Primary Prophylaxis for CMV Infection in Organ Transplant Recipients: A Multicenter Single-arm Prospective Study.
Transplantation · 2025
Donor-derived bartonellosis in solid organ transplant recipients from unhoused donors in Alberta.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2025

All 45 publications

Latest funding

Intracellular uropathogenic bacteria biofilm-like aggregates: A new paradigm in the pathophysiology of urinary tract infections
SSHRC · 2022 · Principal investigator
$121,250
Intracellular uropathogenic bacteria biofilm-like aggregates: A new paradigm in the pathophysiology of urinary tract infections
SSHRC · 2022 · Principal investigator
$121,250
LILRB1 Genetic Variation and the Response to Human Cytomegalovirus
CIHR · 2018 · Principal investigator
$623,475

All 3 grants and awards

45 publications.

Pretransplant screening for infections in lung and heart transplant candidates.

Riunga F, Cervera C, Kabbani D

JHLT open2026

DOI: 10.1016/j.jhlto.2025.100409 PMID: 41356173

Cell-mediated Immunity to Guide Primary Prophylaxis for CMV Infection in Organ Transplant Recipients: A Multicenter Single-arm Prospective Study.

Solera JT, Ferreira VH, Cervera C, Hosseini-Moghaddam SM, Gill J, Shalhoub S, Zaltzman J, Kumar D, Humar A

Transplantation2025

DOI: 10.1097/tp.0000000000005173 PMID: 39160648

Donor-derived bartonellosis in solid organ transplant recipients from unhoused donors in Alberta.

Kabbani D, Orenbuch-Harroch E, Boodman C, Broad S, Paz-Infanzon M, Belga S, Fernández-García OA, Christie E, L N Sikosana M, Shojai S, Gourishankar S, Cervera C, Doucette K

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons2025

DOI: 10.1016/j.ajt.2024.09.026 PMID: 39326850

Clinical management and burden of cytomegalovirus in D+/R-Kidney transplant recipients in Canada

Gill J, House AA, Chagla Z, Tchervenkov J, Kim SJ, Vinson A, Cervera C, Keown PA, Sun SLW, Khoury C

Frontiers in Immunology20252 citations

DOI: 10.3389/fimmu.2025.1618748

Correction: Clinical management and burden of cytomegalovirus in D+/R-Kidney transplant recipients in Canada

Gill J, House AA, Chagla Z, Tchervenkov J, Kim SJ, Vinson A, Cervera C, Keown PA, Sun SLW, Khoury C

Frontiers in Immunology2025

DOI: 10.3389/fimmu.2025.1712602

Incidence of valganciclovir-related leukopenia and neutropenia in solid organ transplant recipients at high risk of cytomegalovirus disease.

Belga S, Hernandez C, Kabbani D, Cervera C

Transplant infectious disease : an official journal of the Transplantation Society2024Senior author

DOI: 10.1111/tid.14227 PMID: 38180285

The impact of colonization by multidrug resistant bacteria on graft survival, risk of infection, and mortality in recipients of solid organ transplant: systematic review and meta-analysis.

Almohaya A, Fersovich J, Weyant RB, Fernández García OA, Campbell SM, Doucette K, Lotfi T, Abraldes JG, Cervera C, Kabbani D

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases2024

DOI: 10.1016/j.cmi.2024.03.036 PMID: 38608872

Cytomegalovirus surveillance after antiviral prophylaxis in CMV mismatched transplant patients: Does recurrent cytomegalovirus DNAemia impact patient survival?

Fernández-García OA, Hernandez C, Robbins M, Kabbani D, Doucette K, Cervera C

Transplant infectious disease : an official journal of the Transplantation Society2024Senior author

DOI: 10.1111/tid.14292 PMID: 38728099

Drug Resistance Assessed in a Phase 3 Clinical Trial of Maribavir Therapy for Refractory or Resistant Cytomegalovirus Infection in Transplant Recipients.

Chou S, Alain S, Cervera C, Chemaly RF, Kotton CN, Lundgren J, Papanicolaou GA, Pereira MR, Wu JJ, Murray RA, Buss NE, Fournier M

The Journal of infectious diseases2024

DOI: 10.1093/infdis/jiad293 PMID: 37506264

Ceftolozane/Tazobactam treatment for patients with hospital-acquired and ventilatory-associated bacterial pneumonia in Canada in 2022–2024: results from the CLEAR registry

Zhanel GG, Dhami R, Baxter M, Wong M, Mirzanejad Y, Kosar J, Cervera C, Irfan N, Borgia S, Serebryanskyy A

Expert Review of Anti-Infective Therapy20242 citations

DOI: 10.1080/14787210.2024.2405930

Something wrong or missing on this profile? Suggest a correction

Carlos Cervera

Research

Latest papers

Latest funding

Pretransplant screening for infections in lung and heart transplant candidates.

Cell-mediated Immunity to Guide Primary Prophylaxis for CMV Infection in Organ Transplant Recipients: A Multicenter Single-arm Prospective Study.

Donor-derived bartonellosis in solid organ transplant recipients from unhoused donors in Alberta.

Clinical management and burden of cytomegalovirus in D+/R-Kidney transplant recipients in Canada

Correction: Clinical management and burden of cytomegalovirus in D+/R-Kidney transplant recipients in Canada

Incidence of valganciclovir-related leukopenia and neutropenia in solid organ transplant recipients at high risk of cytomegalovirus disease.

The impact of colonization by multidrug resistant bacteria on graft survival, risk of infection, and mortality in recipients of solid organ transplant: systematic review and meta-analysis.

Cytomegalovirus surveillance after antiviral prophylaxis in CMV mismatched transplant patients: Does recurrent cytomegalovirus DNAemia impact patient survival?

Drug Resistance Assessed in a Phase 3 Clinical Trial of Maribavir Therapy for Refractory or Resistant Cytomegalovirus Infection in Transplant Recipients.

Ceftolozane/Tazobactam treatment for patients with hospital-acquired and ventilatory-associated bacterial pneumonia in Canada in 2022–2024: results from the CLEAR registry

Intracellular uropathogenic bacteria biofilm-like aggregates: A new paradigm in the pathophysiology of urinary tract infections

Intracellular uropathogenic bacteria biofilm-like aggregates: A new paradigm in the pathophysiology of urinary tract infections

LILRB1 Genetic Variation and the Response to Human Cytomegalovirus

Frequent collaborators

Dima Kabbani

Maryna Yaskina

John Gill

Amanda Vinson

Sergio Borgia

Neal Irfan

Jens Walter

Zain Chagla

Gregory Tyrrell

Atul Humar

Dima Kabbani

Shahid Husain

Deepali Kumar

Jason Weatherald

Shaf Keshavjee

Elie Akl

Lianne Singer

Puneeta Tandon